Newton HS - Search Results

1

Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier.

Avila YI, Chandler M, Cedrone E, Newton HS, Richardson M, Xu J, Clogston JD, Liptrott NJ, Afonin KA, Dobrovolskaia MA. Avila YI, et al. Among authors: newton hs. Molecules. 2021 Jan 27;26(3):652. doi: 10.3390/molecules26030652. Molecules. 2021. PMID: 33513786 Free PMC article.

2

Immunophenotyping: Analytical approaches and role in preclinical development of nanomedicines.

Newton HS, Dobrovolskaia MA. Newton HS, et al. Adv Drug Deliv Rev. 2022 Jun;185:114281. doi: 10.1016/j.addr.2022.114281. Epub 2022 Apr 9. Adv Drug Deliv Rev. 2022. PMID: 35405297 Free PMC article. Review.

3

Immunophenotyping, Part II: Analysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells.

Newton HS, Zhang J, Dobrovolskaia MA. Newton HS, et al. Methods Mol Biol. 2024;2789:269-291. doi: 10.1007/978-1-0716-3786-9_25. Methods Mol Biol. 2024. PMID: 38507010

4

Immunophenotyping, Part I: Instrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures.

Newton HS, Zhang J, Dobrovolskaia MA. Newton HS, et al. Methods Mol Biol. 2024;2789:245-267. doi: 10.1007/978-1-0716-3786-9_24. Methods Mol Biol. 2024. PMID: 38507009

5

Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles.

Newton HS, Zhang J, Donohue D, Unnithan R, Cedrone E, Xu J, Vermilya A, Malys T, Clogston JD, Dobrovolskaia MA. Newton HS, et al. Front Allergy. 2023 Jul 4;4:1126012. doi: 10.3389/falgy.2023.1126012. eCollection 2023. Front Allergy. 2023. PMID: 37470031 Free PMC article.

6

Change in Lipofectamine Carrier as a Tool to Fine-Tune Immunostimulation of Nucleic Acid Nanoparticles.

Newton HS, Radwan Y, Xu J, Clogston JD, Dobrovolskaia MA, Afonin KA. Newton HS, et al. Molecules. 2023 Jun 1;28(11):4484. doi: 10.3390/molecules28114484. Molecules. 2023. PMID: 37298960 Free PMC article.

7

How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity.

Chirra M, Newton HS, Gawali VS, Wise-Draper TM, Chimote AA, Conforti L. Chirra M, et al. Among authors: newton hs. Cancers (Basel). 2022 Jul 22;14(15):3564. doi: 10.3390/cancers14153564. Cancers (Basel). 2022. PMID: 35892822 Free PMC article. Review.

8

Immune Checkpoint Inhibitors Regulate K⁺ Channel Activity in Cytotoxic T Lymphocytes of Head and Neck Cancer Patients.

Gawali VS, Chimote AA, Newton HS, Feria-Garzón MG, Chirra M, Janssen EM, Wise-Draper TM, Conforti L. Gawali VS, et al. Among authors: newton hs. Front Pharmacol. 2021 Aug 27;12:742862. doi: 10.3389/fphar.2021.742862. eCollection 2021. Front Pharmacol. 2021. PMID: 34512366 Free PMC article.

9

Targeted knockdown of the adenosine A_2A receptor by lipid NPs rescues the chemotaxis of head and neck cancer memory T cells.

Newton HS, Chimote AA, Arnold MJ, Wise-Draper TM, Conforti L. Newton HS, et al. Mol Ther Methods Clin Dev. 2021 Mar 4;21:133-143. doi: 10.1016/j.omtm.2021.03.001. eCollection 2021 Jun 11. Mol Ther Methods Clin Dev. 2021. PMID: 33816646 Free PMC article.

10

PD1 blockade enhances K⁺ channel activity, Ca²⁺ signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancer.

Newton HS, Gawali VS, Chimote AA, Lehn MA, Palackdharry SM, Hinrichs BH, Jandarov R, Hildeman D, Janssen EM, Wise-Draper TM, Conforti L. Newton HS, et al. J Immunother Cancer. 2020 Oct;8(2):e000844. doi: 10.1136/jitc-2020-000844. J Immunother Cancer. 2020. PMID: 33060146 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page